跳至主要内容
临床试验/JPRN-UMIN000019869
JPRN-UMIN000019869已完成未知

Catheter closure of patent foramen ovale in patients with cryptogenic cerebrovascular accidents - Catheter closure of patent foramen ovale in patients with cryptogenic cerebrovascular accidents

Okayama University Hospital0 个研究点目标入组 10 人开始时间: 2015年11月20日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
10

研究概览

简要总结

Catheter closure of a patent foramen ovale could be safely performed with Ampatzer Cribriform or Amplatzer PFO Occluder. This procedure may contribute to prevention of recurrent cryptogenic CVA in Japanese patients, especially in patients who have spontaneous interatrial right-to-left shunts.

研究设计

研究类型
Interventional

入排标准

年龄范围
18years-old 至 70years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • other stroke

研究者

相似试验

已完成
不适用
Transcatheter closure of patent foramen ovale in patients with migraineMigraine
JPRN-UMIN000017216Okayama University Hospital30
No Longer Available
不适用
PFO ACCESS RegistryStrokePatent Foramen Ovale
NCT00583401Abbott Medical Devices
进行中(未招募)
不适用
The PROOF Trial - Prospective, Open-label, Multicenter, Non-randomized Investigation on Percutaneous Patent Foramen Ovale (PFO) Closure Using the Occlutech PFO Occluder to Prevent Recurrence of Stroke in Patients With Cryptogenic Stroke and High Risk PFOPFO - Patent Foramen OvaleStroke
NCT04029233Occlutech International AB570
终止
不适用
The Effect of Device Closure of Patent Foramen Ovale in Elderly Patients With Crytogenic Stoke/TCIPFOStrokeTIAPatent Foramen Ovale
NCT01018355Hillerod Hospital, Denmark3,000
进行中(未招募)
1 期
Comparison of three different strategies of preventing a second stroke in patients with a small hole in the wall dividing the right side of the heart from the left side:-two different forms of blood thinning medication: - long-time antiplatelet therapy - long-time anticoagulant therapyor - closure of the hole by implanting a small metal device using a catheter, followed by long-time antiplatelet therapyThe study compares different strategies for secondary stroke (or retinal ischaemia) prevention in patients with patent foramen ovale.The three treatment arms comprise: 1. Endovascular patent foramen ovale closure followed by long-term antiplatelet therapy 2. long-term anticoagulant therapy 3. long-term antiplatelet therapyMedDRA version: 19.0Level: LLTClassification code 10036654Term: PreventionSystem Organ Class: 100000004865MedDRA version: 19.0Level: LLTClassification code 10016982Term: Foramen ovale patentSystem Organ Class: 100000004850MedDRA version: 19.0Level: LLTClassification code 10042244Term: StrokeSystem Organ Class: 100000004852
EUCTR2011-000110-19-DEAssistance Publique – Hôpitaux de Paris (AP-HP)900